Correlation Between Tekla Healthcare and Flaherty Crumrine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tekla Healthcare and Flaherty Crumrine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tekla Healthcare and Flaherty Crumrine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tekla Healthcare Investors and Flaherty Crumrine Preferred, you can compare the effects of market volatilities on Tekla Healthcare and Flaherty Crumrine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tekla Healthcare with a short position of Flaherty Crumrine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tekla Healthcare and Flaherty Crumrine.

Diversification Opportunities for Tekla Healthcare and Flaherty Crumrine

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Tekla and Flaherty is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Tekla Healthcare Investors and Flaherty Crumrine Preferred in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Flaherty Crumrine and Tekla Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tekla Healthcare Investors are associated (or correlated) with Flaherty Crumrine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Flaherty Crumrine has no effect on the direction of Tekla Healthcare i.e., Tekla Healthcare and Flaherty Crumrine go up and down completely randomly.

Pair Corralation between Tekla Healthcare and Flaherty Crumrine

Considering the 90-day investment horizon Tekla Healthcare Investors is expected to under-perform the Flaherty Crumrine. In addition to that, Tekla Healthcare is 2.0 times more volatile than Flaherty Crumrine Preferred. It trades about -0.12 of its total potential returns per unit of risk. Flaherty Crumrine Preferred is currently generating about 0.03 per unit of volatility. If you would invest  913.00  in Flaherty Crumrine Preferred on September 14, 2024 and sell it today you would earn a total of  8.00  from holding Flaherty Crumrine Preferred or generate 0.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.44%
ValuesDaily Returns

Tekla Healthcare Investors  vs.  Flaherty Crumrine Preferred

 Performance 
       Timeline  
Tekla Healthcare Inv 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tekla Healthcare Investors has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
Flaherty Crumrine 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Flaherty Crumrine Preferred are ranked lower than 2 (%) of all funds and portfolios of funds over the last 90 days. In spite of very healthy technical and fundamental indicators, Flaherty Crumrine is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Tekla Healthcare and Flaherty Crumrine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tekla Healthcare and Flaherty Crumrine

The main advantage of trading using opposite Tekla Healthcare and Flaherty Crumrine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tekla Healthcare position performs unexpectedly, Flaherty Crumrine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Flaherty Crumrine will offset losses from the drop in Flaherty Crumrine's long position.
The idea behind Tekla Healthcare Investors and Flaherty Crumrine Preferred pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance